The clinical impact of methylene tetrahydrofolate reductase polymorphism on the vascular complications of sickle cell disease - Egyptian Knowledge Bank - troweb

39252

The clinical impact of methylene tetrahydrofolate reductase polymorphism on the vascular complications of sickle cell disease

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Study of methylenetetraydrofolate reductase gene mutation as a risk factor for deep venous thrombosis

Thesis

The clinical significance of methylenetetrahydrofolate reductase (MTHFR) polymorphisms in acute lymphoblastic leukaemia

Thesis

The effect of methylenetetrahydrofolate reductase gene mutation on plasma homocysteine and incidence in arterial diseases

Thesis

Methyl tetrahydrofolate reductase C677T gene mutation as a risk factor for diabetic nephropathy in type 2 diabetes

Thesis

Association of factor V leiden and prothrombin gene mutations with thrombotic risk in patients with sickle cell anemia

Thesis

Study of glutathione S-transferase gene polymorphisms in sickle cell anemia patients

Thesis

The role of plasma homocysteine and its genetic control as risk factors for thrombophilia

Thesis

Impact of circulating erythrocyte-derived microparticles on coagulation activation insickle cell disease

Thesis

Mannose binding lectin (MBL2) gene variants in sickle cell disease

Thesis

Influence of Iron Regulating genes mutations on iron overload in sickle cell disease